Non-Hodgkin lymphoma pathophysiology: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 107: | Line 107: | ||
|- | |- | ||
| | | | ||
|[[Follicular lymphoma]]<ref name=" | |[[Follicular lymphoma]]<ref name="seer">National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref> | ||
| | | | ||
* Reciprocal translocation t(14;18)(q32;q21). | * Reciprocal translocation t(14;18)(q32;q21). | ||
| | | | ||
*[[Fever]] | |||
*[[Weight loss]] | |||
*[[Night sweats]] | |||
*[[Skin rash]] | |||
*[[Chest pain]] | |||
*[[Abdominal pain]] | |||
*[[Bone pain]] | |||
*[[Cough]] | |||
*[[Dyspnea]] | |||
*Painless swelling in the neck, axilla, groin, thorax and abdomen | |||
| | | | ||
| | | | ||
* [[Lymphadenopathy|Central and peripheral lymphadenopathy]] | |||
* [[Splenomegaly]] | |||
* [[Hepatomegaly]] | |||
* [[Abdominal tenderness]] | |||
* [[Seizures]] | |||
| | | | ||
| | | |
Revision as of 04:04, 27 December 2018
Non-Hodgkin lymphoma Microchapters |
Differentiating Non-Hodgkin's Lymphoma |
---|
Treatment |
Case Studies |
Non-Hodgkin lymphoma pathophysiology On the Web |
American Roentgen Ray Society Images of Non-Hodgkin lymphoma pathophysiology |
Risk calculators and risk factors for Non-Hodgkin lymphoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Non Hodgkin's Lymphoma represents a heterogeneous group of diseases with varied clinical presentation and histological appearance.It arises from cell of the lymphoid system, tumors are mainly derived from B lymphocytes, but are also from T lymphocytes, or natural killer cells. Lymphomas rise from different stages of B and T cell differentiation. Aberrations in the tightly controlled steps of B cell development can lead to oncogenesis. These aberrations are mainly seen in form of chromosomal translocation.
Pathophysiology
Pathogenesis
- Lymphomas can arise from different stages of B cell development:
- B cell development starts in the primary lymphoid tissue, the bone marrow and subsequent maturation takes place in secondary lymphoid tissue (spleen and lymph nodes).
- At the germinal centers of secondary lymphoid tissue B cells encounter antigens via T cells and then undergo affinity maturation to produce immunoglobulins of high affinity.
- It supports rapid B-cell proliferation for immunoglobulin affinity maturation and production of antibody diversity through two processes know as somatic hypermutation (SHM) and immunoglobulin class switching.
- Both of these processes require rapid cell turnover and multiple double stranded DNA breaks, which is error-prone.
- Somatically acquired genetic alterations ( mainly translocations) of these processes is probably the underlying cause of lymphomagenesis.
- The major subtypes of non-hodgkin lymphoma include the following:
- Mature B-cell neoplasms:
- Diffuse large B cell lymphoma
- Follicular lymphoma
- Burkitt lymphoma
- Mantle cell lymphoma
- Hairy cell leukemia
- Extranodal marginal zone lymphoma
- Splenic marginal zone lymphoma
- Plasma cell myeloma
- Mature T and NK neoplasms:
- Mature B-cell neoplasms:
Genetics
Different subtypes of non Hodgkin lymphoma and their genetic involvements::
Pathophysiology | Symptoms | History | Physical Examination | Laboratory Findings | ||||
---|---|---|---|---|---|---|---|---|
Immunochemistry | Blood work | Biospy | ||||||
Diffuse large B-cell lymphoma | Classified into 2 subtypes based on gene expression profiles:
|
|
|
|
|
Centroblastic
Immunoblastic::
Anaplastic:
| ||
Follicular lymphoma[1] |
|
|
||||||
Burkitt lymphoma |
|
|
|
| ||||
B cell lymphoma | Mantle cell lymphoma |
|
|
|
|
|
CBC
|
|
Nodal marginal zone B-cell lymphoma |
|
|
|
|
| |||
Splenic marginal zone lymphoma |
|
| ||||||
Hairy cell leukemia |
|
|
|
| ||||
Plasma cell myeloma | ||||||||
Chronic lymphocytic leukemia / small lymphocytic lymphoma | ||||||||
Monoclonal B-cell lymphocytosis | ||||||||
B-cell prolymphocytic leukemia | ||||||||
Waldenström's macroglubulinemia | ||||||||
Monoclonal gammopathy of undetermined significance (MGUS) | ||||||||
Heavy chain disease | ||||||||
Solitary plasmacytoma of bone | ||||||||
Extraosseous plasmacytoma | ||||||||
Monoclonal immunoglobulin deposition diseases | ||||||||
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | ||||||||
Large B-cell lymphoma with IRF4 rearrangement | ||||||||
Primary cutaneous follicle center lymphoma | ||||||||
T-cell/histiocyte-rich large B-cell lymphoma | ||||||||
Lymphomatoid granulomatosis | ||||||||
Primary mediastinal (thymic) large B-cell lymphoma | ||||||||
Intravascular large B-cell lymphoma | ||||||||
ALK1 large B-cell lymphoma | ||||||||
Plasmablastic lymphoma | ||||||||
Primary effusion lymphoma | ||||||||
High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | ||||||||
T cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
||||
T-cell granular lymphocytic leukemia |
|
Symptoms of T-cell large granular lymphocyte leukemia may include the following: |
|
|
| |||
Subcutaneous panniculitis-like T-cell lymphoma |
- ↑ National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov
Associated Conditions
Conditions associated with [disease name] include:
- [Condition 1]
- [Condition 2]
- [Condition 3]
Gross Pathology
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
Genetics
The development of Non-Hodgkin lymphoma is the result of multiple genetic mutations such as:[1][2]
- Mutations of the B-cell receptor genes and NFKB pathway
- RNA splicing mutations in the small lymphocytic lymphoma
- Genetic mutations in histone formation:[3]
- MLL2
- MEF2B
- EZH2
- CREBBP
- EP300
- MLL2
Gross Pathology
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
Microscopic Pathology
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
References
- ↑ Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A; et al. (2011). "Analysis of the coding genome of diffuse large B-cell lymphoma". Nat Genet. 43 (9): 830–7. doi:10.1038/ng.892. PMC 3297422. PMID 21804550.
- ↑ Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C; et al. (2012). "Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing". Proc Natl Acad Sci U S A. 109 (10): 3879–84. doi:10.1073/pnas.1121343109. PMC 3309757. PMID 22343534.
- ↑ Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL; et al. (2013). "Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma". Blood. 121 (9): 1604–11. doi:10.1182/blood-2012-09-457283. PMC 3587323. PMID 23297126.